AVALISSE is a prescription medication used to treat adults with low platelet counts due to chronic immune thrombocytopenia (ITP) when a prior treatment for ITP has not worked well enough. .
N. Connel, N Berlin, Fostamatinib for the treatment of chronic immune thrombocytopenia. Blood (2019) 133 (19): 20272030.
A) Nephropathy”. ClinicalTrials.gov. Retrieved 19 November 2016.
“Drug Approval Package: Tavalisse (fostamatinib disodium hexahydrate)”. U.S. Food and Drug Administration (FDA). 15 May 2018
Tavalisse Prescribing Information 2022